The Acquired Immunodeficiency Syndrome in Haiti
- JEAN W. PAPE, M.D.;
- BERNARD LIAUTAUD, M.D.;
- FRANCK THOMAS, M.D.;
- JEAN-ROBERT MATHURIN, M.D.;
- MARIE-MYRTHA A. ST. AMAND, M.D.;
- MADELEINE BONCY;
- VERGNIAUD PEAN, M.D.;
- MOLIERE PAMPHILE, M.D.;
- A. CLAUDE LAROCHE, M.D.;
- JACK DEHOVITZ, M.D., M.P.H.; and
- WARREN D. JOHNSON, M.D.
Abstract
Two hundred twenty-nine patients in Haiti with the acquired immunodeficiency syndrome were studied between 1979 and 1984. The clinical spectrum of the syndrome in Haitians was similar in most aspects to that in patients with the disease in the United States. However, in contrast to findings in the United States, accepted risk factors (bisexuality, blood transfusions, intravenous drug abuse) were identified in only 43% of Haitian patients. Patients in Haiti with and without these risk factors were similar to each other but differed from age- and sexmatched siblings and friends in the number of heterosexual contacts and receipt of intramuscular injections. These latter activities were commoner in patients than in their siblings and friends, and represent potential modes of transmission of infection with the human T-lymphotropic virus type III.
Article and Author Information
-
▸ From the Haitian Study Group on Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti; and the Department of Medicine, Division of International Medicine, Cornell University Medical College, New York, New York.
-
Grant support: by grants CA 35018 and AI 22624 from the National Institutes of Health.
-
▸ Requests for reprints should be addressed to Warren D. Johnson, M.D.; Department of Medicine, Cornell University Medical College, 1300 York Avenue; New York, NY 10021.
- © 1985 American College of Physicians
Most Read